Table 1

Baseline characteristics by % predicted FEV1 in 3242 men with no prior heart failure or myocardial infarction

 % predicted FEV1
≤5th percentile6–24th percentile25–49th percentile50–74th percentile≥75th percentilep Difference between groups
No. of men162651810813806
Range FEV1, % predicted<48.4 48.4–75.075.1–89.0 89.1–101.6≥101.7
FEV (L)1.12 (0.26)1.92 (0.31)2.49 (0.31)2.86 (0.34)3.33 (0.47)
FVC (L)2.12 (0.09)2.77 (0.06)3.27 (0.06)3.64 (0.06)4.13 (0.07)
% FEV1/FVC<0.733.334.130.326.821.1
Categorical variables (%)
 Smokers27.221.413.88.54.7<0.001
 Manual63.662.554.051.345.8<0.001
 Inactive54.439.031.630.826.2<0.001
 Heavy drinkers 6.25.23.24.23.00.083
 Diabetes14.816.012.410.810.40.001
 Stroke6.85.55.12.83.40.017
 AF3.73.53.52.82.40.620
 Antihypertensive use33.334.130.326.821.1<0.001
 Left ventricular hypertrophy5.66.37.38.98.20.302
Continuous variables (means)
 Age (years)69.4 (5.4)69.1 (5.4)68.0 (5.2)67.8 (5.5)68.9 (5.7)<0.001
 BMI (kg/m2)25.5 (3.9)27.1 (4.0)27.1 (3.7)26.9 (3.3)26.4 (3.2)<0.001
 Systolic blood pressure (mm Hg)147.8 (21.9)151.5 (25.4)149.2 (23.5)150.8 (24.1)148.7 (22.9)0.090
 Cholesterol (mmol/L)5.86 (1.10)5.93 (1.02)6.10 (1.10)6.09 (1.04)6.09 (1.06)0.002
 High-density lipoprotein-cholesterol (mmol/L)1.41 (0.41)1.31 (0.35)1.32 (0.34)1.31 (0.33)1.36 (0.33)0.002
 C-reactive protein (mg/L)*4.48 (1.30–6.01)2.27 (1.08–4.82)1.82 (0.90–3.47)1.38 (0.73–2.87)1.23 (0.60–2.40)<0.001
 N-terminal pro-brain natriuretic peptide (pg/mL)*115.6 (55–257)108.9 (49–220)86.5 (44–160)77.5 (38–147)80.6 (41–146)<0.001
  Cardiac troponin T (pg/mL)*13.7 (10.1–18.9)12.4 (9.3–16.4)11.2 (8.6–15.9)11.0 (8.5–14.8)11.0 (8.2–14.7)<0.001
  • Mean and SD unless specified.

  • *Geometric mean and IQR.